Investigating the biology of remyelination.

From a biological idea to a measurable question

In multiple sclerosis, injury to myelin and nerve cells can affect neurological function. The Green Lab studies biological markers of repair and progression to support the development and evaluation of potential reparative therapies.

Connecting laboratory and clinical research

The lab’s work spans biological validation and clinical trials. ReCOVER examines clemastine in acute optic neuritis; ReVIVE uses MRI measurements in people with multiple sclerosis.

These are research studies of an investigational use. Their inclusion here does not establish clemastine as an approved treatment for myelin repair.

Selected evidence

Adapted from the source research information.